New Key Statistics Module, Z-Score and F-Score
OTCPK:OPHLY Key Ratios
| Market Cap $ M | 6,877.29 |
| Enterprise Value $ M | 6,093.71 |
| P/E(ttm) | 7.93 |
| PE Ratio without NRI | 7.93 |
| Forward PE Ratio | -- |
| Price/Book | 1.39 |
| Price/Sales | 2.15 |
| Price/Free Cash Flow | 11.89 |
| Price/Owner Earnings | 10.15 |
| Payout Ratio % | 0.29 |
| Revenue (TTM) $ M | 3,507.00 |
| EPS (TTM) $ | 0.61 |
| Beneish M-Score | -2.11 |
| 10-y EBITDA Growth Rate % | 19.60 |
| 5-y EBITDA Growth Rate % | 18.90 |
| y-y EBITDA Growth Rate % | 14.80 |
| EV-to-EBIT | 5.22 |
| EV-to-EBITDA | 4.71 |
| PEG | 0.42 |
| Shares Outstanding M | 1,409.28 |
| Net Margin (%) | 25.62 |
| Operating Margin % | 32.93 |
| Pre-tax Margin (%) | 33.42 |
| Quick Ratio | 3.43 |
| Current Ratio | 3.95 |
| ROA % (ttm) | 14.59 |
| ROE % (ttm) | 16.85 |
| ROIC % (ttm) | 19.41 |
| Dividend Yield % | 3.61 |
| Altman Z-Score | 9.32 |
| Piotroski F-Score | 7.00 |
| Positive ROA | Y |
| Positive CFROA | Y |
| Higher ROA y-y | Y |
| Cash flow > Earnings | N |
| Lower Leverage y-y | Y |
| Higher Current Ratio y-y | N |
| Less Shares Outstanding y-y | Y |
| Gross Margin Increase y-y | Y |
| Higher Asset Turnover y-y | Y |
OPHLY Number of Guru Trades
OPHLY Volume of Guru Trades
Gurus Latest Trades with OTCPK:OPHLY
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:OPHLY is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Ono Pharmaceutical Co Ltd Insider Transactions
No Available Data
News about OTCPK:OPHLY
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers